Citrin Cooperman Advisors LLC, the premier professional services provider for private, middle market businesses and high net-worth individuals, today announced it has entered into an agreement to ...
Reported three-month complete response rate of 77.8% from the Phase 3 UTOPIA trial of UGN-103, consistent with ENVISION results; FDA agreed to regulatory plan to submit an NDA based on data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback